Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drug Volume: Type and usage volumes of pharmaceuticals.
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Type Benchmarking
6.3.1 Type specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Type launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. gRNA Market Segmentation, by Type
7.1 Chapter Overview
7.2 Research-Use
7.2.1 Research-Use Market Trends Analysis (2020-2032)
7.2.2 Research-Use Market Size Estimates and Forecasts to 2032 (USD Million)
7.3 GMP-grade
7.3.1 GMP-grade Market Trends Analysis (2020-2032)
7.3.2 GMP-grade Market Size Estimates and Forecasts to 2032 (USD Million)
8. gRNA Market Segmentation, by Application
8.1 Chapter Overview
8.2 Genome Engineering
8.2.1 Genome Engineering Market Trends Analysis (2020-2032)
8.2.2 Genome Engineering Size Estimates and Forecasts to 2032 (USD Million)
8.3 Disease Model Studies
8.3.1 Disease Model Studies Market Trends Analysis (2020-2032)
8.3.2 Disease Model Studies Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Functional Genomics
8.4.1 Functional Genomics Market Trends Analysis (2020-2032)
8.4.2 Functional Genomics Size Estimates and Forecasts to 2032 (USD Million)
8.5 Epigenetics
8.5.1 Epigenetics Market Trends Analysis (2020-2032)
8.5.2 Epigenetics Market Size Estimates and Forecasts to 2032 (USD Million)
8.6 Others
8.6.1 Others Market Trends Analysis (2020-2032)
8.6.2 Others Size Estimates and Forecasts to 2032 (USD Million)
9. gRNA Market Segmentation, by End Use
9.1 Chapter Overview
9.2 Pharmaceutical & Biotechnology Companies
9.2. Pharmaceutical & Biotechnology Companies Market Trends Analysis (2020-2032)
9.2.2 Pharmaceutical & Biotechnology Companies Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Academic Research Institutes
9.3.1 Academic Research Institutes Market Trends Analysis (2020-2032)
9.3. Academic Research Institutes Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 CMOs & CROs
9.4.1 CMOs & CROs Market Trends Analysis (2020-2032)
9.4.2 CMOs & CROs Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.4 North America gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.5 North America gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.6.2 USA gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.6.3 USA gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.7.2 Canada gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.7.3 Canada gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.8.2 Mexico gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.8.3 Mexico gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.4 Eastern Europe gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.5 Eastern Europe gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.6.2 Poland gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.6.3 Poland gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.7.2 Romania gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.7.3 Romania gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.8.2 Hungary gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.8.3 Hungary gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.9 Turkey
10.3.1.9.1 Turkey gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.9.2 Turkey gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.9.3 Turkey gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.4 Western Europe gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.5 Western Europe gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.6.2 Germany gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.6.3 Germany gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.7.2 France gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.7.3 France gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.8.2 UK gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.8.3 UK gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.9.2 Italy gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.9.3 Italy gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.10.2 Spain gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.10.3 Spain gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.11.2 Netherlands gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.11.3 Netherlands gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.12.2 Switzerland gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.12.3 Switzerland gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.13.2 Austria gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.13.3 Austria gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia-Pacific gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.4 Asia-Pacific gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.5 Asia-Pacific gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.6.2 China gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.6.3 China gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.7.2 India gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.7.3 India gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.8.2 Japan gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.8.3 Japan gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.9.2 South Korea gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.9.3 South Korea gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.10.2 Vietnam gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.10.3 Vietnam gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.11.2 Singapore gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.11.3 Singapore gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.12.2 Australia gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.12.3 Australia gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.4.13 Rest of Asia-Pacific
10.4.13.1 Rest of Asia-Pacific gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.4.13.2 Rest of Asia-Pacific gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.13.3 Rest of Asia-Pacific gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.4 Middle East gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.5 Middle East gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.6.2 UAE gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.6.3 UAE gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.7.2 Egypt gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.7.3 Egypt gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.9.2 Qatar gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.9.3 Qatar gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.4 Africa gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.5 Africa gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.6.2 South Africa gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.6.3 South Africa gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.7.2 Nigeria gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.7.3 Nigeria gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America gRNA Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.4 Latin America gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.5 Latin America gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.6.2 Brazil gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.6.3 Brazil gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.7.2 Argentina gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.7.3 Argentina gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.8.2 Colombia gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.8.3 Colombia gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America gRNA Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America gRNA Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America gRNA Market Estimates and Forecasts, by End Use (2020-2032) (USD Million)
11. Company Profiles
11.1 Jena Bioscience GmbH
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Types/ Services Offered
11.1.4 SWOT Analysis
11.2 Thermo Fisher Scientific Inc.
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Types/ Services Offered
11.2.4 SWOT Analysis
11.3 Synbio Technologies
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Types/ Services Offered
11.3.4 SWOT Analysis
11.4 Merck KGaA
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Types/ Services Offered
11.4.4 SWOT Analysis
11.5 Takara Bio Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Types/ Services Offered
11.5.4 SWOT Analysis
11.6 Horizon Discovery Ltd.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Types/ Services Offered
11.6.4 SWOT Analysis
11.7 Agilent Technologies Inc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Types/ Services Offered
11.7.4 SWOT Analysis
11.8 System Biosciences, LLC.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Types/ Services Offered
11.8.4 SWOT Analysis
11.9 Synthego
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Types/ Services Offered
11.9.4 SWOT Analysis
11.10 GENEWIZ (Azenta Life Sciences)
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Types/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
